<DOC>
	<DOCNO>NCT00432393</DOCNO>
	<brief_summary>Purpose : There controversy effect Levodopa-Carbidopa treatment non-arteritic anterior ischemic optic neuropathy ( NAION ) . This study perform evaluate effect Levodopa-Carbidopa visual acuity , color vision , visual field patient recent onset NAION ( less 6 week duration ) . Patients Methods : In double-blind randomized clinical trial , 13 patient treat levodopa-carbidopa 12 patient take placebo 3 week . Visual acuity , color vision , visual field test 4th , 12th , 16th , 24th week enrollment , evaluate .</brief_summary>
	<brief_title>Effect Levodopa-Carbidopa Visual Function Patients With Recent-Onset Nonarteritic Anterior Ischemic Optic Neuropathy</brief_title>
	<detailed_description />
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Optic Nerve Diseases</mesh_term>
	<mesh_term>Optic Neuropathy , Ischemic</mesh_term>
	<mesh_term>Carbidopa</mesh_term>
	<mesh_term>Carbidopa , levodopa drug combination</mesh_term>
	<mesh_term>Levodopa</mesh_term>
	<criteria>age great 50 year old first ophthalmic examination within 6 week onset disease presence optic disc swell follow optic atrophy within 6 week altitudinal , central generalize visual field defect normal ESR confirm giant cell arteritis history ocular surgery optic neuropathy due acute bleed advanced diabetic retinopathy uncontrolled glaucoma ocular disorder cause visual acuity reduction rather NAION</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2007</verification_date>
</DOC>